The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,024.00
Bid: 11,500.00
Ask: 12,200.00
Change: 0.00 (0.00%)
Spread: 700.00 (6.087%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,024.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-U.S. directs millions of COVID-19 shots to Latin America, Africa, Asia

Mon, 21st Jun 2021 17:33

(Adds comments from White House spokesperson)

By Jeff Mason

June 21 (Reuters) - The White House laid out a plan on
Monday to share 55 million U.S. COVID-19 vaccine doses globally,
with roughly 75% of the doses allocated to Latin America and the
Caribbean, Asia and Africa through the COVAX international
vaccine-sharing program.

The plan fulfills President Joe Biden's commitment to share
80 million U.S.-made vaccines with countries around the world.
The president sketched out his priorities for the first 25
million doses from that pledge earlier this month.

The United States has come under pressure to share more of
its vaccine supply with countries that are still struggling with
the deadly virus and its variants. With more and more Americans
getting the shots, the White House increasingly has turned its
attention to getting vaccine out internationally. (Graphic on
global vaccinations) https://tmsnrt.rs/3tUM8ta

Of the 55 million remaining doses, some 41 million will be
shared through COVAX, the White House said, with approximately
14 million going to Latin America and the Caribbean, some 16
million to Asia, and roughly 10 million to Africa.

The other 25%, or roughly 14 million doses, will be shared
with "regional priorities," including Colombia, Argentina, Iraq,
Ukraine, the West Bank and Gaza.

White House spokeswoman Jen Psaki said the United States had
faced logistical issues getting vaccine to other nations.

"We have plenty of doses to share with the world, but this
is a Herculean logistical challenge," she told reporters, noting
safety and regulatory information had to be shared, proper
storage temperatures for the vaccines had to be ensured, and
language barriers at times had to be overcome.

"We have announced today where these doses are going. We
will continue to announce as they land on the ground and as they
are being shipped, and we're looking forward to doing that as
quickly as possible," she said.

The 55 million doses will be taken from the U.S. supply of
Pfizer Inc, Moderna Inc, and Johnson & Johnson
shots, though if AstraZeneca's vaccine gets a
green light from the Food and Drug Administration, it would
likely be added to the mix as well.

The White House said it wanted the doses to be prioritized
for health care workers and those who are most at risk.

International partners are eager to get U.S. help. Biden has
announced the United States will buy 500 million doses of
Pfizer's vaccine and donate them to the world's poorest
countries.

The White House's breakdown of its allocation of the 55
million vaccine doses is below.

THROUGH COVAX:

* Latin America and the Caribbean (approximately 14 million
shots): Brazil, Argentina, Colombia, Peru, Ecuador, Paraguay,
Bolivia, Uruguay, Guatemala, El Salvador, Honduras, Haiti, and
other Caribbean Community (CARICOM) countries, Dominican
Republic, Panama, and Costa Rica

* Asia (approximately 16 million shots): India, Nepal,
Bangladesh, Pakistan, Sri Lanka, Afghanistan, Maldives, Bhutan,
Philippines, Vietnam, Indonesia, Thailand, Malaysia, Laos, Papua
New Guinea, Taiwan, Cambodia, and the Pacific Islands.

* Africa (approximately 10 million shots): Recipient
countries will be selected in coordination with the African
Union.

THROUGH DIRECT SHARING: Colombia, Argentina, Haiti, other
CARICOM countries, Dominican Republic, Costa Rica, Panama,
Afghanistan, Bangladesh, Pakistan, Philippines, Vietnam,
Indonesia, South Africa, Nigeria, Kenya, Ghana, Cabo Verde,
Egypt, Jordan, Iraq, Yemen, Tunisia, Oman, West Bank and Gaza,
Ukraine, Kosovo, Georgia, Moldova, and Bosnia.

(Reporting by Jeff Mason
Additional reporting by Trevor Hunnicutt and Nandita Bose
Editing by Chizu Nomiyama and Lisa Shumaker)

More News
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.